去乙酰毛花苷注射液和胺碘酮治疗急诊危重症合并快速心律失常的随机对照研究

A randomized controlled study of deacetylglycosin injection and amiodarone in the treatment of emergency critical patients combined with tachyarrhythmia

目的:探讨去乙酰毛花苷注射液和胺碘酮治疗急诊危重症合并快速心律失常的临床疗效。方法:2018年2月-2019年2月收治急诊危重症合并快速心律失常患者80例,随机分为两组,各40例。观察组给予胺碘酮治疗;对照组给予去乙酰毛花苷注射液治疗。比较两组治疗效果。结果:观察组治疗后心功能各项指标水平均显著优于对照组,差异有统计学意义(P<0.05)。观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论:应用胺碘酮治疗急诊危重症伴快速心律失常患者,可显著减少不良反应,改善患者心功能。

Objective:To compare the clinical efficacy of deacetylglycosin injection and amiodarone in the treatment of critical patients combined with tachyarrhythmia.Methods:From February 2018 to February 2019,80 cases of critical patients combined with tachyarrhythmia were selected,and randomly divided into the two groups with 40 patients in each group.The observation group was treated with amiodarone.The control group was treated with deacetylglycosin injection.The therapeutic effects between the two groups was compared.Results:After treatment,the cardiac function various indicators levels of the observation group were significantly better than the control group,with the differences were statistically significant(P<0.05).The incidence of adverse reactions in the observation group was lower than the control group,with the difference was statistically significant(P<0.05).Conclusion:Amiodarone in the treatment of patients with emergency critical patients combined with tachyarrhythmia can significantly reduce the incidence of adverse reactions and improve patients'cardiac function.